According to a new study, a group of researchers found that a cancer drug available at present could have the potential to treat muscular dystrophy. The researchers from the University of British Columbia's School of Biomedical Engineering found that the drug -- known as a colony-stimulating factor 1 receptor inhibitor -- helped slow the progress of Duchenne muscular dystrophy in …
